Voices
David Planchard: Sequential Biopsy Study in 100 NSCLC Patients Through the UNLOCK Program
David Planchard/oncostream.com

David Planchard: Sequential Biopsy Study in 100 NSCLC Patients Through the UNLOCK Program

David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinkedIn:

“Incredible teamwork with French thoracic oncologists and our research teams at Gustave Roussy!

This unique project features sequential biopsies from 100 NSCLC patients via the Unlock program. Brilliant coordination by Barbara Pistilli. Deeply grateful to the pts and Daiichi-Sankyo.”David Planchard: Sequential Biopsy Study in 100 NSCLC Patients Through the UNLOCK Program

Title: ICARUS-LUNG01: A phase 2 Study of Dato-DXd in
patients with previously treated advanced NSCLC, with
sequential tissue biopsies and biomarkers analysis to
predict treatment outcome

Authors: D. Planchard, N. Cozic, M. Wislez, C. Chouaid, H. Curcio, S. Cousin, C. Mascaux, J. Cadranel, M. Geier, M. R. Ghigna, G. Nachabeh, R. Zwirtes, R. Chiaverelli, R. Cheikh-Hussin, N. Corcos, F. Mosele, F. André, G. Montagnac, B. Pistilli

Read the Full Article.

David Planchard: Sequential Biopsy Study in 100 NSCLC Patients Through the UNLOCK Program

Other Articles Featuring David Planchard on OncoDaily.

B. Pistilli Barbara Pistilli C. Chouaïd C. Mascaux cancer D. Planchard David Planchard F. André F. Mosele G. Montagnac G. Nachabeh H. Curcio ICARUS-LUNG01 J Cadranel Lung cancer M. Geier M. R. Ghigna M. Wislez N. Corcos N. Cozic NSCLC OncoDaily Oncology R. Cheikh-Hussin R. Chiaverelli R. Zwirtes S. Cousin